Cutaneous manifestations of strongyloides stercoralis hyperinfection in an HIV-seropositive patient

SKINmed

Volumn 9, Issue 3, 2011, Pages 199-202

  Martin, Stephanie J ^a   Cohen, Philip R ^a,b,c   MacFarlane, Deborah F ^a,b   Grossman, Marc E ^d  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b University of Texas Health Science Center at Houston   (United States)

^c UNIVERSITY OF HOUSTON   (United States)

^d University of Houston ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHELMINTIC AGENT; IVERMECTIN; TIABENDAZOLE;

ADULT; AIDS RELATED COMPLEX; ANIMAL; ARTICLE; CASE REPORT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ISOLATION AND PURIFICATION; MALE; PARASITIC SKIN DISEASE; PARASITOLOGY; STRONGYLOIDES STERCORALIS; STRONGYLOIDIASIS;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANIMALS; ANTHELMINTICS; HIV SEROPOSITIVITY; HUMANS; IVERMECTIN; MALE; SKIN DISEASES, PARASITIC; STRONGYLOIDES STERCORALIS; STRONGYLOIDIASIS; THIABENDAZOLE;

EID: 79959804719     PISSN: 15409740     EISSN: 17517125     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Kalb RE, Grossman ME. Periumbilical purpura in disseminated strongyloidiasis. JAMA. 1986;256:1170-1171.
2. Basile A, Simzar S, Bentow J, et al. Disseminated Strongyloides stercoralis: hyperinfection during medical immunosuppression. J Am Acad Dermatol. 2010;63:896-902.
3. Salluh JI, Bozza FA, Pinto TS, et al. Cutaneous periumbilical purpura in disseminated strongyloidiasis in cancer patients: a pathognomonic feature of potentially lethal disease? Braz J Infect Dis. 2005;9:419-424.
4. Weiser JA, Scully BE, Bulman WA, Husain S, Grossman ME. Periumbilical parasitic thumbprint purpura: strongyloides hyperinfection syndrome acquired from a cadaveric renal transplant. Transpl Infect Dis. 2010 May 26. doi 10.1111/j.1399-3062.2010.00516.x.
5. Patel G, Arvelakis A, Sauter BV, et al. Strongyloides hyperinfection syndrome after intestinal transplantation. Transpl Infect Dis. 2008;10:137-141.
6. Keiser PB, Nutman TB. Strongyloides stercoralis in the immunocompromised population. Clin Microbiol Rev. 2004;17:208-217.
7. Reddy TS, Myers JW. Syndrome of inappropriate secretion of antidiuretic hormone and nonpalpable purpura in a woman with Strongyloides stercoralis hyperinfection. Am J Med Sci. 2003;325:288-291.
8. Greiner K, Bettencourt J, Semolic C. Strongyloidiasis: a review and update by case example. Clin Lab Sci. 2008;21:82-88.
9. Concha R, Harrington W, Rogers A. Intestinal strongyloidiasis: recognition, management, and determinants of outcomes. J Clin Gastroenterol. 2005;39:203-211.
10. Chaudhary K, Smith RJ, Himelright IM, et al. Case report: purpura in disseminated strongyloidiasis. Am J Med Sci. 1994;308:186-191.
11. Simpson WG, Gerhardstein DC, Thompson JR. Disseminated Strongyloides stercoralis infection. South Med J. 1993;86:821-825.
12. Jacob CI, Patten SF. Strongyloides stercoralis infection presenting as generalized prurigo nodularis and lichen simplex chronicus. J Am Acad Dermatol. 1999;41:357-361.
13. Von Kuster LC, Genta RM. Cutaneous manifestations of strongyloidiasis. Arch Dermatol. 1988;124:1826-1830.
14. Bank DE, Grossman ME, Kohn SR, et al. The thumbprint sign: rapid diagnosis of disseminated strongyloidiasis. J Am Acad Dermatol. 1990;23:324-326.
15. Smith JD, Goette DK, Odom RB. Larva currens. Cutaneous strongyloidiasis. Arch Dermatol. 1976;112:1161-1163.
16. Lam CS, Tong MK, Chan KM, et al. Disseminated strongyloidiasis: a retrospective study of clinical course and outcome. Eur J Clin Microbiol Infect Dis. 2006;25:14-18.
17. Segarra-Newnham M. Manifestations, diagnosis, and treatment of Strongyloides stercoralis infection. Ann Pharmacother. 2007;41:1992-2001.
18. Blendis L, Wong F. The hyperdynamic circulation in cirrhosis: an overview. Pharmacol Ther. 2001;89:221-231.
19. Bon B, Houze S, Talabani H, et al. Evaluation of a rapid enzymelinked immunosorbent assay for diagnosis of strongyloidiasis. J Clin Microbiol. 2010;48:1716-1719.
20. Grossman ME, Roth J. Cutaneous Signs of Infection in the Immunocompromised Host. Philadelphia, PA: Lippincott Williams and Wilkins; 1995:143-147.